MedPath

Rocuronium

These highlights do not include all the information needed to use ROCURONIUM BROMIDE INJECTION safely and effectively. See full prescribing information for ROCURONIUM BROMIDE INJECTION. ROCURONIUM BROMIDE injection solution for intravenous use Initial U.S. Approval: 1994

Approved
Approval ID

98255b70-51f9-8d16-e053-2995a90a8f97

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 21, 2023

Manufacturers
FDA

Piramal Critical Care Inc

DUNS: 805600439

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Rocuronium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66794-228
Application NumberANDA210437
Product Classification
M
Marketing Category
C73584
G
Generic Name
Rocuronium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (5)

SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
ROCURONIUM BROMIDEActive
Quantity: 50 mg in 5 mL
Code: I65MW4OFHZ
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

Rocuronium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66794-229
Application NumberANDA210437
Product Classification
M
Marketing Category
C73584
G
Generic Name
Rocuronium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 21, 2023
FDA Product Classification

INGREDIENTS (5)

SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
ROCURONIUM BROMIDEActive
Quantity: 100 mg in 10 mL
Code: I65MW4OFHZ
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rocuronium - FDA Drug Approval Details